MicroRNA, a nucleic acid like DNA, is present in plants and animals. Out of the thousands of identified sequences, a subset is highly elevated in a number of human cancers.
They are found in blood, urine and saliva, and detecting them is a high priority for biomedical researchers.
At present, detecting them from a blood test requires going to a clinic.
Now, researchers from University of Rhode Island (URI) in the US have their sights set on continuous home monitoring that could generate automatic alerts.
The procedure is relatively noninvasive compared to, say, surgical biopsy, they said.
"We could detect a signal from deep within a mouse," said Daniel Roxbury, assistant professor at URI.
"It is certainly a monumental step. The next stage would be to construct some kind of wearable device, maybe a wristwatch, that incorporates this technology," said Roxbury.
The research was published in the journal Nature Biomedical Engineering.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
